account_balance
Investment manager · 13F filer · SEC CIK 1545692
NVP Associates, LLC
Reported value$328Mas of Jun 30, 2026
Positions7 3 new, 1 sold out
Top 10 weight100.0%MBX alone is 36%
FiledAug 738 days after quarter end
Portfolio · as of Jun 30, 2026
Where the money is
New or addedTrimmedHeld
This fund reports 7 stocks.
MBXMBX Biosciences Inc
35.9%
AVLNAvalyn Pharmaceuticals Inc
22.8%New
OMDAOmada Health Inc
16.9%
ZBIOZenas Biopharma Inc
14.2%
SNOWSnowflake Inc
8.9%New
GROVMBXMBX Biosciences Inc
35.9%
AVLNAvalyn Pharmaceuticals Inc
22.8%New
OMDAOmada Health Inc
16.9%
ZBIO14.2%SNOW8.9%GROVBox size is the share of the fund. 13F only covers US-listed stocks, so foreign holdings and short positions are missing.
What changed